🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
PM8002 (BNT327) is a bispecific antibody targeting PD-L1 and VEGF. This is ...
Status
Recruiting
Location
Peking University First Hospital
Start Date
2025-08-19
Trial ID
NCT07133750
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and effi...
Status
Recruiting
Location
Local Institution - 0178
Start Date
2026-03-26
Trial ID
NCT07293351
Treatments Being Tested
This multi-site Phase II study will enroll adults with histologically confi...
Status
Recruiting
Location
Beijing Tiantan Hospital, Capital Medical University
Start Date
2026-01-15
Trial ID
NCT07297212
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, and effica...
Status
Recruiting
Location
Local Institution - 0170
Start Date
2026-08-15
Trial ID
NCT07680764
Surgical intervention remains the primary treatment option for early-stage ...
Status
Not Yet Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2025-02-18
Trial ID
NCT06837948
Treatments Being Tested
This is a Phase III trial where participants will be randomized to two trea...
Status
Recruiting
Location
Highlands Oncology Group
Start Date
2025-10-30
Trial ID
NCT07173751
Treatments Being Tested
This multicenter, randomized, double-blind study will evaluate the safety a...
Status
Active Not Recruiting
Location
The first affiliated hospital of bengbu medical University
Start Date
2024-06-11
Trial ID
NCT06419621
Treatments Being Tested
PM8002 is a bispecific antibody targeting PD-L1 and VEGF. This study will e...
Status
Active Not Recruiting
Location
Binzhou Medical University Hospital
Start Date
2024-11-13
Trial ID
NCT06616532
Treatments Being Tested
This is a Phase 2/3, multisite, randomized, open-label study in participant...
Status
Recruiting
Location
Birmingham Hematology and Oncology Associates LLC d/b/a Alabama Oncology
Start Date
2025-01-07
Trial ID
NCT06712316
Treatments Being Tested
This is a multi-site, open-label, dose-finding study, consisting of Parts 1...
Status
Recruiting
Location
UCLA Hematology Oncology - Main Site
Start Date
2025-09-22
Trial ID
NCT07111520